Parent Feedback on the Reducing Emotional Distress for Childhood Hypoglycemia in Parents (REDCHiP) Intervention: A

Nicole A Kahhan1, MaryJane S Campbell2, Mark A Clements3

  • 1Division of Psychology, Nemours Children's Health-Jacksonville, 807 Children's Way, Jacksonville, FL 32207, USA.

PubMed

Insights

Parents of young children with type 1 diabetes mellitus (T1DM) fear hypoglycemia. The REDCHiP intervention helped parents manage this fear, with most intending to use learned skills.

Area of Science:

  • Pediatric Endocrinology
  • Behavioral Psychology
  • Clinical Intervention Research

Background:

  • Severe hypoglycemia is a significant concern for young children with type 1 diabetes mellitus (T1DM).
  • Parents of these children frequently experience intense hypoglycemia fear (HF), potentially leading to maladaptive behaviors.
  • The REDCHiP intervention was developed to address HF in parents of young children with T1DM.

Purpose of the Study:

  • To qualitatively analyze parent feedback on the REDCHiP intervention.
  • To refine and optimize future iterations of the REDCHiP intervention for parents of young children with T1DM.
  • To understand parent perceptions of intervention components and their intention to apply learned skills.

Main Methods:

  • A randomized pilot study involved 73 parents of young children with T1DM participating in a 10-session video-based intervention.
  • Qualitative analysis of 21 recordings from the final intervention session, focusing on parent feedback.
  • Independent coding of sessions to identify themes related to active treatment components and process.

Main Results:

  • Coded themes identified the use of Cognitive Behavioral Therapy (CBT) skills, coping strategies, and behavioral parenting strategies as active treatment components.
  • Parents expressed appreciation for REDCHiP content and provided examples of applied skills.
  • Key challenges in applying REDCHiP strategies were also identified, alongside parents' intentions for future skill application.

Conclusions:

  • Qualitative analysis revealed parent perceptions of REDCHiP's active components, their acceptability, and the intention to integrate skills into daily T1DM care.
  • Findings offer insights for refining the intervention to better support parents.
  • Future research should explore alternative delivery formats to enhance accessibility and scalability.
Abstract

Related Concept Videos

SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.3K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
34